Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesChronic Kidney Disease
You have accessRestricted Access

Black Americans’ Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease

Ebele M. Umeukeje, Marcus G. Wild, Saugar Maripuri, Teresa Davidson, Margaret Rutherford, Khaled Abdel-Kader, Julia Lewis, Consuelo H. Wilkins and Kerri Cavanaugh
CJASN April 2018, 13 (4) 551-559; DOI: https://doi.org/10.2215/CJN.07580717
Ebele M. Umeukeje
1Vanderbilt Center for Kidney Disease, Nashville, Tennessee;
2Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus G. Wild
3Department of Psychology, Vanderbilt University, Nashville, Tennessee;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saugar Maripuri
4Division of Nephrology, Hennepin County Medical Center, Minneapolis, Minnesota;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Davidson
5Tennessee Kidney Foundation, Nashville, Tennessee;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Rutherford
6The University of North Carolina, Chapel Hill, North Carolina; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khaled Abdel-Kader
1Vanderbilt Center for Kidney Disease, Nashville, Tennessee;
2Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Lewis
1Vanderbilt Center for Kidney Disease, Nashville, Tennessee;
2Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Consuelo H. Wilkins
7Meharry–Vanderbilt Alliance, Nashville, Tennessee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerri Cavanaugh
1Vanderbilt Center for Kidney Disease, Nashville, Tennessee;
2Division of Nephrology, Vanderbilt University Medical Center, Nashville, Tennessee;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Visual Overview

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

Background and objectives Incidence of ESKD is three times higher in black Americans than in whites, and CKD prevalence continues to rise among black Americans. Community-based kidney disease screening may increase early identification and awareness of black Americans at risk, but it is challenging to implement. This study aimed to identify participants’ perspectives of community kidney disease screening. The Health Belief Model provides a theoretic framework for conceptualization of these perspectives and optimization of community kidney disease screening activities.

Design, setting, participants, & measurements Researchers in collaboration with the Tennessee Kidney Foundation conducted three focus groups of adults in black American churches in Nashville, Tennessee. Questions examined views on CKD information, access to care, and priorities of kidney disease health. Content analysis was used. Guided by the Health Belief Model, a priori themes were generated, and additional themes were derived from the data using an inductive approach.

Results Thirty-two black Americans completed the study in 2014. Participants were mostly women (79%) with a mean age of 56 years old (range, 24–78). Two major categories of barriers to kidney disease screening were identified: (1) participant factors, including limited kidney disease knowledge, spiritual/religious beliefs, emotions, and culture of the individual; and (2) logistic factors, including lack of convenience and incentives and poor advertisement. Potential facilitators of CKD screening included provision of CKD education, convenience of screening activities, and use of culturally sensitive and enhanced communication strategies. Program recommendations included partnering with trusted community members, selecting convenient locations, tailored advertising, and provision of compensation.

Conclusions Findings of this study suggest that provider-delivered culturally sensitive education and stakeholder engagement are critical to increase trust, decrease fear, and maximize participation and early identification of kidney disease among black Americans considering community screening.

  • chronic kidney disease
  • clinical nephrology
  • ethnicity
  • Adult
  • United States
  • Female
  • Prevalence
  • Incidence
  • Focus Groups
  • Motivation
  • Research Personnel
  • Tennessee
  • African Americans
  • Kidney Diseases
  • Kidney Failure, Chronic
  • kidney
  • Fear
  • Emotions

Introduction

CKD is a public health concern affecting approximately 26 million United States adults, and another 20 million have risk factors for its development (1). Additionally, black Americans have a greater prevalence of macroalbuminuria compared with whites (2), a faster rate of progression to ESKD (3), and a persistently higher incidence of ESKD, which is estimated at three times that of whites (4). An analysis of recent trends in the United States revealed the stabilization of CKD prevalence in all racial subgroups, with the exception of black Americans (1). Explanatory factors for this continued rise in CKD prevalence in black Americans remain unknown and warrant aggressive examination. One cohort study has suggested that the disproportionate excess risk of CKD incidence in black Americans compared with whites may be explained in part by access to health care (5).

A common strategy to promote awareness of a health condition and identify individuals at risk is community-based health programs. Examples of this type of program specific to kidney disease include the National Kidney Foundation Kidney Early Evaluation Program (KEEP) (6,7) and the Kidney Disease Screening and Awareness Program, which focuses on underserved populations (8). The KEEP has been successful at identifying individuals at risk for kidney disease and advancing kidney disease knowledge to influence public health policies and practices (6). Despite the availability of community kidney disease screening, the participation rate is not optimal (6). People choose not to attend health-screening events for various reasons, such as lack of time and knowledge about the disease condition, fear of testing physicality, and potentially serious diagnoses (9,10). It has previously been suggested that black Americans are less likely to take advantage of screening programs (11) because of their limited knowledge of kidney disease (12) and low perceived susceptibility to CKD (13).

Previous research has identified barriers to seeking or accessing preventative care (14–16), and this is particularly true in black Americans (17). However, there is limited information specific to black Americans and their participation in kidney disease community screening. The Health Belief Model is a sociopsychologic theoretic framework that is widely and effectively used to explain health-seeking behavior influencing participation in screening tests (18–20). It posits that the motivation to undertake health behavior is informed by six critical elements of patients’ health beliefs: perceived seriousness, perceived susceptibility, perceived barriers versus benefits, perceived threat, self-efficacy, and cues to action. Informed by the Health Belief Model, the objective of this study was to assemble perspectives from black Americans who would be potential participants in a community screening for kidney disease program on the barriers and facilitators of successful engagement.

Materials and Methods

Participant Selection

In partnership with the Tennessee Kidney Foundation Kidney Awareness Risk Evaluation program (www.tennesseekidneyfoundation.org/programs-education/) and a network of black American churches in Nashville, Tennessee, fliers and verbal announcements were used to invite participants to focus groups. Participants were eligible if they were English-speaking black American adults at least 18 years old. They consisted of general community members and included those who had previously participated in kidney disease screening events as well as those who had not. The Vanderbilt University Medical Center Institutional Review Board approved this study, and all participants provided written informed consent.

Data Collection

During the focus group, participants completed a brief demographic survey. Focus group discussions lasted about 60 minutes each and were completed between August and December 2014. The discussions were led by a clinician researcher (E.M.U.) trained in moderating group discussions. A third party note taker was present to take detailed notes regarding the course of the focus group discussions, and all sessions were audio recorded and transcribed verbatim.

The focus group guide was developed by the research team through literature review (9,10,15,16,21) and uniformly used for all of the sessions (Supplemental Material). The Health Belief Model was used as a theoretic model to inform the generation of questions for the focus group guide and preset codes for qualitative content analysis. The focus group sessions were conducted until evidence of saturation of themes was noted.

Analyses

Transcriptions were analyzed using the HyperRESEARCH (version 3.5.2; ResearchWare Inc., Randolph, MA) qualitative data analysis software. Applying qualitative content analysis methodology (22–24) with combined deductive and inductive approach (23,25), open coding was performed. Guided by the Health Belief Model, a priori themes were deductively generated. Additional themes were inductively derived from the transcripts. The initial training included a partial coding of one of the focus group sessions to ensure that all definitions were set and clear among the coders. Three research team members (E.M.U., M.W., and M.R.) assigned theme and subtheme codes to each idea fragment. New codes were generated as needed. Any discrepancies in the coding were reconciled among the three coders, and a fourth member of the team (K.C.) provided input as needed for final reconciliation of the codes. Summary descriptive tables are reported.

Results

The numbers of participants in each focus group session were eight, ten, and 14 in the first, second, and third sessions, respectively (n=32). Participant characteristics are shown in Table 1. The mean age of the participants was 56 years old (SD=13), the majority was women (79%), and all were black American. Most had more than a high school education (82%) and health insurance (91%). Few self-reported a diagnosis of kidney disease (3%), but most reported having known risk factors, such as hypertension (70%), diabetes mellitus (24%), or a family history of kidney disease (27%). Participants also acknowledged family members receiving dialysis or having had a kidney transplant.

View this table:
  • View inline
  • View popup
Table 1.

Characteristics of black American participants in focus groups that assessed barriers and facilitators of community screening for kidney disease

Barriers

Important individual and programmatic logistic factors influencing perceived barriers to CKD screening were discovered. These included four major themes: (1) knowledge of kidney disease and its associated risk factors; (2) cultural factors, such as limited trust; (3) emotions, including denial and fear; and (4) environmental and socioeconomic issues, including poor availability of health care and limited financial resources (Table 2).

View this table:
  • View inline
  • View popup
Table 2.

Selected quotations to illustrate barriers by themes in focus groups that assessed barriers and facilitators of community screening for kidney disease

View this table:
  • View inline
  • View popup
Table 3.

Selected quotations to illustrate facilitators by themes in focus groups that assessed barriers and facilitators of community screening for kidney disease

Kidney Disease Knowledge

Limited Understanding of CKD.

Participants agreed that there was a lack of health knowledge in their community, including knowledge specific to CKD and its associated consequences. They felt that there was a paucity of information about CKD compared with the robust awareness about other diseases, such as heart disease and breast cancer. They also felt that this limitation in knowledge of CKD significantly contributed to a lack of adherence to prescribed medical therapy and self-care practices in addition to having a negative effect on the community’s degree of interest in screening for kidney disease.

Poor Understanding of Associated Risk Factors/Manifestations of CKD.

Participants expressed that their community did not know the risk factors for CKD. The participants also expressed uncertainty about the causes and significance of markers of kidney disease, such as proteinuria.

Low Health Literacy.

Participants noted that use of medical jargon and terms during screenings contributed to a low interest in participating. This was especially influential for people who have difficulty navigating the health care system.

Limited Appreciation of Long-Term Benefits of Screening.

The participants reflected on previous health screening events and reported that people prioritized attendance at job fairs or hair fairs over health fairs, because they disregarded the potential benefits of CKD screening, such as early diagnosis, establishing connections with health care, and early intervention to improve health outcomes. Participants also noted that some families experienced longevity even in the setting of CKD; therefore, the value of directly addressing it was questioned.

Lack of CKD Education and Testing from Providers.

Participants attributed the limited knowledge about CKD to a lack of counseling and testing by their current and previous clinical health care providers. Participants felt that often physicians did not routinely discuss health issues that could result from risk factors until people either became symptomatic or had abnormal laboratory results. They also admitted that they were reluctant to inquire about kidney health during their interactions with their primary care provider because of embarrassment and reluctance to display ignorance.

“Ignorance is Bliss.”

Ignorance was identified as a potential factor impeding participation in CKD screening. Participants attributed this ignorance to a lack of knowledge about kidney disease and its related risk factors as well as a lack of readiness to make health behavior changes. Participants suggested that community members may opt to be ignorant, because they prefer not to be aware of any existing diagnoses. This was felt to be more common in men.

Cultural

Low Trust.

The participants identified low trust in health care providers, the health care system, and community health screening events. Participants expressed that low trust in physicians was a primary reason that they do not engage with health evaluations. A specific concern was that urine tests were performed for drug screening rather than proteinuria.

Limited Value for Health.

Participants felt that there was a limited appreciation of health and resultant lack of motivation for health-promoting behavior by some people in their community.

Strong Spirituality Beliefs.

Participants expressed the belief that God was responsible for taking care of their bodies. They suggested that, sometimes, some people in their community stretched this belief to the extent that they give up their own responsibility for appropriate self-care practices and rather, focus on extensive prayers and faith-building practices.

Fear of Side Effects, Ego, and Machismo.

These were identified as factors that deterred men from participating in screening events. It was suggested that men worried about potential decrease in libido and sex drive from medications, such as antihypertensives. Participants also suggested that men resist the prospect of being labeled with a diagnosis that would force them to assume a “sick role,” which they felt would challenge their manhood.

Emotions

Explicit Kidney Disease–Related Fears.

Participants were specifically afraid of the possibility of being diagnosed with a disease that could lead to dialysis. There was controversy over whether this fear was more prevalent among older people in the community versus younger people, but there was agreement that this fear contributed significantly to nonparticipation in screening.

Fear of Embarrassment and Violation of Privacy.

Participants were concerned about health privacy at community events, because they are typically in a public venue. They reported that people would be even less likely to participate in screening events if conducted at their location of employment.

Environmental and Socioeconomic

Financial Burden of Disease if Diagnosed.

There was concern that the financial burden of disease if diagnosed deterred people from participating in community screening, including those who have health insurance but are unable to afford deductibles or medication payments. Conversely, participants also highlighted the fact that some people who had poor access to health care resources may default to health fairs for medical evaluation.

Lack of Convenience.

There was a unanimous agreement that optimal participation in screening events was affected by convenience. The timing and location of screening events were identified as highly important. They agreed that work places were not convenient for health screening fairs. There was no discussion about possible cost associated with attending screening health fairs, and participants did not express specific concerns about transportation costs related to health screening events.

Poor/Trivial Advertisement.

Participants expressed the notion that health fairs were not often optimally advertised, and they expressed concern over limited awareness of kidney disease compared with other disease conditions, such as cancer, heart disease, etc.

Lack of Onsite Incentives.

Participants felt that participation in health fairs is limited in the absence of onsite incentives. “No one wants to show up at a health fair just to get stuck with a needle and to get a urine test” (Focus Group 3: Participant 3).

Facilitators

Key facilitators to CKD screening events were identified and categorized into four major themes: (1) increased CKD knowledge, (2) culturally sensitive strategies, (3) enhanced communication strategies, and (4) convenience. There was unanimous consensus on the need for CKD education and testing from providers. Integration of culturally sensitive strategies was emphasized, and participants suggested that participation in health fairs was partly dependent on the assurance that people’s trusted friends, trusted religious leaders, or other respected members of the community would attend the screening events. They also suggested the need for incorporating specific strategies targeting increased participation from younger people.

Enhanced communication strategies were highlighted, including the critical role of physicians in communicating CKD information and results; use of tailored advertisement strategies; communication of relevant information, such as statistics about CKD; and full disclosure of use of biologic specimens in health fairs to dispel fears, build trust, and increase participation.

Many of the participants shared the view that the church or community center was often a preferred location and that weekends were more convenient. It was also suggested that the screening flow at health fairs should be structured in a standardized and consistent manner to avoid any sense of embarrassment, which participants may feel if they have the perception of having been singled out for additional diagnostic screening or additional counseling on the basis of the finding of an abnormal result. Participants highlighted that there was an existing notion in the community that people had to be incentivized to attend health fairs. These incentives ranged from the prospects of exciting “side attractions” at the health fairs, such as aerobics class, line dancing, and health walks, to even “bounce houses” for kids.

Discussion

In this study, we applied the Health Belief Model to examine the knowledge and the psychologic factors influencing the uptake of community screening for kidney disease among black Americans. We also organized the themes of participants’ views into an architectural framework derived from this model to conceptualize preventive health behaviors (Figure 1) (26). The themes that are centered on knowledge, attitudes, and fears affect people’s perception of susceptibility to and severity of CKD. These both directly influence people’s perception of threat related to CKD diagnosis, which is also affected by underlying trust and communication factors. Tailored advertisement strategies and positive peer pressure are important examples of “cues to action.” The balance between the perceptions of barriers (including logistic factors) and benefits of participation in CKD screening in combination with the individual’s perception of threat of CKD and cues to action culminate in the decision to participate in community CKD screening.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Application of the Health Belief Model to assess barriers and facilitators of community screening for kidney disease.

We broadly classified the key identified factors into person-centered factors and programmatic factors. The person-centered factors included trust; communication; emotions, such as fear and denial; kidney knowledge; and socioeconomic constraints. The program factors included convenience, privacy, and expectation of tangible benefits from participation in CKD screening.

Our findings confirmed those identified in previous research evaluating screening behavior in other chronic disease conditions (10,16,21,27) and CKD (15); however, we noted important novel barriers. We identified that, in black Americans, trust and effective communication from physicians about kidney disease were important in achieving optimal participation in community CKD screening.

Low trust among black Americans is associated with low participation in clinical research (28), including cancer (29) and cardiovascular disease prevention trials (30). Black Americans also report less trust in their physicians (31,32). Limited trust in the health care system by black Americans is associated with lower use of general preventative health services, such as dental and vision screening (33) and less use of women-specific preventative health screening, including pap smear and mammography (34). It even affects the uptake of prostate cancer screening resources (35–37). Our findings suggest that this extends beyond the health care setting to affect community efforts to improve health, such as kidney disease screening. More specifically, we discovered that participants were distrustful of urine collection during CKD screening, because they suspected that it would be used for purposes other than screening for proteinuria, such as drug testing. CKD screening programs need to make overt declarations of the purpose and use of any biologic specimens to build confidence and not deter participation.

Communication in addition to trust have been jointly identified as keys to promoting positive health behaviors, such as medication adherence and regular attendance at appointments for medical evaluation (10,38). Among black Americans, positive physician affect has been directly linked to patient trust (39), and “trustworthy” communication has been shown to enhance the effectiveness of outreach calls promoting colorectal cancer screening (40). These findings suggest that culturally sensitive health communication is also crucial in community screening for high-risk minority populations (21). This involves training program staff in communication skills that will facilitate rapport building, positive affect, and trust building.

Knowledge is a fundamental component of developing a true appreciation for one’s own health status, risk of future poor health, and risks or benefits of specific behaviors. Low levels of perceived CKD knowledge have been identified even among patients who have active follow-up in a CKD clinic, and they are associated with poor ratings of their physician’s communication (41). Methods to improve patient kidney knowledge in clinical encounters and more broadly, the community are important to increase awareness of susceptibility to CKD and encourage CKD screening. The National Kidney Disease Education Program (42), among others, offers tools that can be used by clinicians in either of these settings.

A key belief expressed was that people are absolved of the responsibility of self-care, because “God will take care of them.” Consideration for the spirituality of patients with CKD should be encouraged because of its direct correlation with health-related quality of life, mental health, and life expectancy (43). Collaboration with community spiritual leaders, especially to endorse rationale for screening participation, is also recommended in programs for black Americans.

Programmatic considerations were also identified as significant contributors to screening nonparticipation. In addition to convenience of screening locations, embarrassment associated with privacy was identified as a barrier to participation in screening. Participants suggested that there may be stigma related to the diagnosis of kidney disease. Chronic disease–specific stigma is emerging as a critical factor in diabetes diagnosis and self-care (44). Particular attention to the structure of the venue and ways to protect privacy with curtains or other visual barriers are required. Incentives, such as gift items, free food, and entertainment, were identified as major motivators for participation in CKD screening health fairs. This is similar to findings in other minority and economically disadvantaged populations (16,27) and can be addressed using the input of respected community leaders to shift people’s focus away from the expectation of tangible compensation toward the conviction of potential long-term benefits accrued from early diagnosis and early intervention.

A key strength of this study is the fact that it identifies both individual and programmatic factors important to black Americans, and it provides detailed examples that can be acted on to improve community CKD screening. Importantly, this study captures the views of people who are at risk for kidney disease. Our sample size was small and limited to black Americans in one geographic area of the United States, potentially limiting the generalizability of our findings to all black American patients or other racial or ethnic subgroups. We also acknowledge that a couple of the focus group sessions had a large sample size, which could lead to split conversations and also, limit participants’ opportunity to speak; however, deliberate steps were taken to minimize chances of these happening. Furthermore, although we reached theoretic saturation overall and captured a wide range of demographic characteristics of black American participants, this sample was composed of fairly highly educated black Americans, and there was a limited proportion of men. However, the beliefs discussed here are held by some black Americans in Tennessee; they may hold true for black Americans in other parts of the United States, and they may affect participation in kidney disease screening events.

This study identified key issues that may inform the future design of more effective, culturally sensitive community CKD screening programs targeting vulnerable minority population who are at high risk for kidney disease. Our findings emphasize the need for establishing strong collaborative partnerships with community leaders and stakeholders, with the aim of building trust among minority populations. These stakeholders will facilitate the dissemination of information and help optimize the logistics of upcoming health fairs. Our findings also emphasize the need to ensure that screening practices are standardized for all participants, regardless of results, to avoid any perception of breech of health privacy. The flow at screening events, use of biologic specimens, and details of screening practices should be fully disclosed. Programs and communities that address each of these pathways will effectively engage more black American participants in the goal to prevent kidney disease.

Disclosures

None.

Acknowledgments

We acknowledge support from the Tennessee Kidney Foundation (TKF) and Teresa Davidson (CEO of TKF from November 2004 to October 2015). This work was supported, in part, by National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases grants F32DK102366 (to E.M.U.), T32DK007569 (to E.M.U. and S.M.), and K23DK080952 (to K.C.). K.A.-K. was supported by NIH Career Development award K23DK090304. K.C. is further supported by NIH grant R01DK03935-01A1.

This work was presented as a poster at the 2015 Vanderbilt Master of Public Health Practicum Colloquium in Nashville, Tennessee, January 20, 2015. An abstract was presented at the 2016 National Kidney Foundation Spring Clinical Meeting in Boston, Massachusetts, April 27–May 1.

E.M.U. and K.C. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • See related editorial, “Community-Based CKD Screening in Black Americans,” on pages 521–523.

  • This article contains supplemental material online at http://cjasn.asnjournals.org/lookup/suppl/doi:10.2215/CJN.07580717/-/DCSupplemental.

  • Received July 17, 2017.
  • Accepted December 18, 2017.
  • Copyright © 2018 by the American Society of Nephrology

References

  1. ↵
    1. Murphy D,
    2. McCulloch CE,
    3. Lin F,
    4. Banerjee T,
    5. Bragg-Gresham JL,
    6. Eberhardt MS,
    7. Morgenstern H,
    8. Pavkov ME,
    9. Saran R,
    10. Powe NR,
    11. Hsu CY; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team
    : Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med 165: 473–481, 2016pmid:27479614
    OpenUrlCrossRefPubMed
  2. ↵
    1. Coresh J,
    2. Byrd-Holt D,
    3. Astor BC,
    4. Briggs JP,
    5. Eggers PW,
    6. Lacher DA,
    7. Hostetter TH
    : Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180–188, 2005pmid:15563563
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Hunsicker LG,
    2. Adler S,
    3. Caggiula A,
    4. England BK,
    5. Greene T,
    6. Kusek JW,
    7. Rogers NL,
    8. Teschan PE
    : Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908–1919, 1997pmid:9186882
    OpenUrlCrossRefPubMed
  4. ↵
    1. Lipworth L,
    2. Mumma MT,
    3. Cavanaugh KL,
    4. Edwards TL,
    5. Ikizler TA,
    6. Tarone RE,
    7. McLaughlin JK,
    8. Blot WJ
    : Incidence and predictors of end stage renal disease among low-income blacks and whites. PLoS One 7: e48407, 2012pmid:23110237
    OpenUrlCrossRefPubMed
  5. ↵
    1. Evans K,
    2. Coresh J,
    3. Bash LD,
    4. Gary-Webb T,
    5. Köttgen A,
    6. Carson K,
    7. Boulware LE
    : Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant 26: 899–908, 2011pmid:20688771
    OpenUrlCrossRefPubMed
  6. ↵
    1. Vassalotti JA,
    2. Li S,
    3. Chen SC,
    4. Collins AJ
    : Screening populations at increased risk of CKD: The Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 53[Suppl 3]: S107–S114, 2009pmid:19231754
    OpenUrlCrossRefPubMed
  7. ↵
    1. Whaley-Connell AT,
    2. Tamura MK,
    3. Jurkovitz CT,
    4. Kosiborod M,
    5. McCullough PA
    : Advances in CKD detection and determination of prognosis: Executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report. Am J Kidney Dis 61[Suppl 2]: S1–S3, 2013pmid:23507265
    OpenUrlPubMed
  8. ↵
    1. Hsiao LL,
    2. Wu J,
    3. Yeh AC,
    4. Shieh EC,
    5. Cui C,
    6. Li A,
    7. Polding LC,
    8. Ahmed R,
    9. Lim K,
    10. Lu TS,
    11. Rhee CM,
    12. Bonventre JV
    : The Kidney Disease Screening and Awareness Program (KDSAP): A novel translatable model for increasing interest in nephrology careers. J Am Soc Nephrol 25: 1909–1915, 2014pmid:24876120
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Eborall H,
    2. Stone M,
    3. Aujla N,
    4. Taub N,
    5. Davies M,
    6. Khunti K
    : Influences on the uptake of diabetes screening: A qualitative study in primary care. Br J Gen Pract 62: e204–e211, 2012
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Legido-Quigley H,
    2. Camacho Lopez PA,
    3. Balabanova D,
    4. Perel P,
    5. Lopez-Jaramillo P,
    6. Nieuwlaat R,
    7. Schwalm JD,
    8. McCready T,
    9. Yusuf S,
    10. McKee M
    : Patients’ knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: A qualitative study. PLoS One 10: e0122112, 2015pmid:25909595
    OpenUrlPubMed
  11. ↵
    1. Waterman AD,
    2. Browne T,
    3. Waterman BM,
    4. Gladstone EH,
    5. Hostetter T
    : Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis 51: 554–562, 2008pmid:18371531
    OpenUrlCrossRefPubMed
  12. ↵
    1. Wright JA,
    2. Wallston KA,
    3. Elasy TA,
    4. Ikizler TA,
    5. Cavanaugh KL
    : Development and results of a kidney disease knowledge survey given to patients with CKD. Am J Kidney Dis 57: 387–395, 2011pmid:21168943
    OpenUrlCrossRefPubMed
  13. ↵
    1. Boulware LE,
    2. Carson KA,
    3. Troll MU,
    4. Powe NR,
    5. Cooper LA
    : Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med 24: 1123–1129, 2009pmid:19711135
    OpenUrlCrossRefPubMed
  14. ↵
    1. Deskins S,
    2. Harris CV,
    3. Bradlyn AS,
    4. Cottrell L,
    5. Coffman JW,
    6. Olexa J,
    7. Neal W
    : Preventive care in Appalachia: Use of the theory of planned behavior to identify barriers to participation in cholesterol screenings among West Virginians. J Rural Health 22: 367–374, 2006
    OpenUrlCrossRefPubMed
  15. ↵
    1. Jennette CE,
    2. Vupputuri S,
    3. Hogan SL,
    4. Shoham DA,
    5. Falk RJ,
    6. Harward DH
    : Community perspectives on kidney disease and health promotion from at-risk populations in rural North Carolina, USA. Rural Remote Health 10: 1388, 2010pmid:20504048
    OpenUrlPubMed
  16. ↵
    1. Murimi MW,
    2. Harpel T
    : Practicing preventive health: The underlying culture among low-income rural populations. J Rural Health 26: 273–282, 2010
    OpenUrlCrossRefPubMed
  17. ↵
    1. Goldade K,
    2. Sidhwani S,
    3. Patel S,
    4. Brendt L,
    5. Vigliaturo J,
    6. Kasiske B,
    7. Ahluwalia JS,
    8. Israni AK
    : Kidney transplant patients’ perceptions, beliefs, and barriers related to regular nephrology outpatient visits. Am J Kidney Dis 57: 11–20, 2011pmid:21087814
    OpenUrlPubMed
  18. ↵
    1. Gillam SJ
    : Understanding the uptake of cervical cancer screening: The contribution of the health belief model. Br J Gen Pract 41: 510–513, 1991
    OpenUrlAbstract/FREE Full Text
    1. Sung JJ,
    2. Choi SY,
    3. Chan FK,
    4. Ching JY,
    5. Lau JT,
    6. Griffiths S
    : Obstacles to colorectal cancer screening in Chinese: A study based on the health belief model. Am J Gastroenterol 103: 974–981, 2008pmid:18047545
    OpenUrlCrossRefPubMed
  19. ↵
    1. Taheri-Kharameh Z,
    2. Noorizadeh F,
    3. Sangy S,
    4. Zamanian H,
    5. Shouri-Bidgoli AR,
    6. Oveisi H
    : Factors associated with adherence to colorectal cancer screening among moderate risk individuals in Iran. Asian Pac J Cancer Prev 16: 8371–8375, 2015pmid:26745087
    OpenUrlPubMed
  20. ↵
    1. Massaro E,
    2. Claiborne N
    : Effective strategies for reaching high-risk minorities with diabetes. Diabetes Educ 27: 820–828, 2001
    OpenUrlCrossRefPubMed
  21. ↵
    1. Hsieh HF,
    2. Shannon SE
    : Three approaches to qualitative content analysis. Qual Health Res 15: 1277–1288, 2005pmid:16204405
    OpenUrlCrossRefPubMed
  22. ↵
    1. Elo S,
    2. Kyngäs H
    : The qualitative content analysis process. J Adv Nurs 62: 107–115, 2008pmid:18352969
    OpenUrlCrossRefPubMed
  23. ↵
    1. Berg BL
    : An introduction to content analysis. In: Qualitative Research Methods for the Social Sciences, 5th Ed, Boston, Pearson/Allyn & Bacon, 2004 pp 265–298
  24. ↵
    1. Cho JY,
    2. Lee E
    : Reducing confusion about grounded theory and qualitative content analysis: Similarities and differences. Qual Rep 19: 1–20, 2014
    OpenUrl
  25. ↵
    1. Orji R,
    2. Vassileva J,
    3. Mandryk R
    : Towards an effective health interventions design: An extension of the health belief model. Online J Public Health Inform 4: pii: ojphi.v4i3.4321, 2012pmid:23569653
    OpenUrlPubMed
  26. ↵
    1. Shah VO,
    2. Ghahate DM,
    3. Bobelu J,
    4. Sandy P,
    5. Newman S,
    6. Helitzer DL,
    7. Faber T,
    8. Zager P
    : Identifying barriers to healthcare to reduce health disparity in Zuni Indians using focus group conducted by community health workers. Clin Transl Sci 7: 6–11, 2014pmid:24528897
    OpenUrlCrossRefPubMed
  27. ↵
    1. Corbie-Smith G,
    2. Thomas SB,
    3. St George DM
    : Distrust, race, and research. Arch Intern Med 162: 2458–2463, 2002pmid:12437405
    OpenUrlCrossRefPubMed
  28. ↵
    1. Haynes-Maslow L,
    2. Godley P,
    3. Dimartino L,
    4. White B,
    5. Odom J,
    6. Richmond A,
    7. Carpenter W
    : African American women’s perceptions of cancer clinical trials. Cancer Med 3: 1430–1439, 2014pmid:24905181
    OpenUrlCrossRefPubMed
  29. ↵
    1. Braunstein JB,
    2. Sherber NS,
    3. Schulman SP,
    4. Ding EL,
    5. Powe NR
    : Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore) 87: 1–9, 2008pmid:18204365
    OpenUrlCrossRefPubMed
  30. ↵
    1. Peek ME,
    2. Gorawara-Bhat R,
    3. Quinn MT,
    4. Odoms-Young A,
    5. Wilson SC,
    6. Chin MH
    : Patient trust in physicians and shared decision-making among African-Americans with diabetes. Health Commun 28: 616–623, 2013pmid:23050731
    OpenUrlCrossRefPubMed
  31. ↵
    1. Boulware LE,
    2. Cooper LA,
    3. Ratner LE,
    4. LaVeist TA,
    5. Powe NR
    : Race and trust in the health care system. Public Health Rep 118: 358–365, 2003
    OpenUrlCrossRefPubMed
  32. ↵
    1. Strickland J,
    2. Strickland DL
    : Barriers to preventive health services for minority households in the rural south. J Rural Health 12: 206–217, 1996
    OpenUrlCrossRefPubMed
  33. ↵
    1. O’Malley AS,
    2. Sheppard VB,
    3. Schwartz M,
    4. Mandelblatt J
    : The role of trust in use of preventive services among low-income African-American women. Prev Med 38: 777–785, 2004pmid:15193898
    OpenUrlCrossRefPubMed
  34. ↵
    1. Carpenter WR,
    2. Godley PA,
    3. Clark JA,
    4. Talcott JA,
    5. Finnegan T,
    6. Mishel M,
    7. Bensen J,
    8. Rayford W,
    9. Su LJ,
    10. Fontham ET,
    11. Mohler JL
    : Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Cancer 115: 5048–5059, 2009pmid:19637357
    OpenUrlCrossRefPubMed
    1. Jones RA,
    2. Steeves R,
    3. Williams I
    : How African American men decide whether or not to get prostate cancer screening. Cancer Nurs 32: 166–172, 2009pmid:19258830
    OpenUrlCrossRefPubMed
  35. ↵
    1. Jones RA,
    2. Steeves R,
    3. Williams I
    : Family and friend interactions among African-American men deciding whether or not to have a prostate cancer screening. Urol Nurs 30: 189–193, 2010
    OpenUrlPubMed
  36. ↵
    1. Khatib R,
    2. Schwalm JD,
    3. Yusuf S,
    4. Haynes RB,
    5. McKee M,
    6. Khan M,
    7. Nieuwlaat R
    : Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: A systematic review and meta-analysis of qualitative and quantitative studies. PLoS One 9: e84238, 2014pmid:24454721
    OpenUrlCrossRefPubMed
  37. ↵
    1. Martin KD,
    2. Roter DL,
    3. Beach MC,
    4. Carson KA,
    5. Cooper LA
    : Physician communication behaviors and trust among black and white patients with hypertension. Med Care 51: 151–157, 2013pmid:23132201
    OpenUrlCrossRefPubMed
  38. ↵
    1. Albright K,
    2. Richardson T,
    3. Kempe KL,
    4. Wallace K
    : Toward a trustworthy voice: Increasing the effectiveness of automated outreach calls to promote colorectal cancer screening among African Americans. Perm J 18: 33–37, 2014pmid:24867548
    OpenUrlCrossRefPubMed
  39. ↵
    1. Wright Nunes JA,
    2. Wallston KA,
    3. Eden SK,
    4. Shintani AK,
    5. Ikizler TA,
    6. Cavanaugh KL
    : Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int 80: 1344–1351, 2011pmid:21832984
    OpenUrlCrossRefPubMed
  40. ↵
    1. Huang ES,
    2. Brown SE,
    3. Thakur N,
    4. Carlisle L,
    5. Foley E,
    6. Ewigman B,
    7. Meltzer DO
    : Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care 32: 311–316, 2009pmid:19017766
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Fradelos EC,
    2. Tzavella F,
    3. Koukia E,
    4. Papathanasiou IV,
    5. Alikari V,
    6. Stathoulis J,
    7. Panoutsopoulos G,
    8. Zyga S
    : Integrating chronic kidney disease patient’s spirituality in their care: Health benefits and research perspectives. Mater Sociomed 27: 354–358, 2015pmid:26622206
    OpenUrlPubMed
  42. ↵
    1. Browne JL,
    2. Ventura AD,
    3. Mosely K,
    4. Speight J
    : Measuring the stigma surrounding type 2 diabetes: Development and validation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2). Diabetes Care 39: 2141–2148, 2016pmid:27515964
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 13 (4)
Clinical Journal of the American Society of Nephrology
Vol. 13, Issue 4
April 06, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Black Americans’ Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Black Americans’ Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease
Ebele M. Umeukeje, Marcus G. Wild, Saugar Maripuri, Teresa Davidson, Margaret Rutherford, Khaled Abdel-Kader, Julia Lewis, Consuelo H. Wilkins, Kerri Cavanaugh
CJASN Apr 2018, 13 (4) 551-559; DOI: 10.2215/CJN.07580717

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Black Americans’ Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease
Ebele M. Umeukeje, Marcus G. Wild, Saugar Maripuri, Teresa Davidson, Margaret Rutherford, Khaled Abdel-Kader, Julia Lewis, Consuelo H. Wilkins, Kerri Cavanaugh
CJASN Apr 2018, 13 (4) 551-559; DOI: 10.2215/CJN.07580717
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States
  • Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
  • Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
Show more Original Articles

Chronic Kidney Disease

  • NAT8 Variants, N-Acetylated Amino Acids, and Progression of CKD
  • Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes
  • Combination Treatment with Sodium Nitrite and Isoquercetin on Endothelial Dysfunction among Patients with CKD
Show more Chronic Kidney Disease

Cited By...

  • Race in America: What Does It Mean for Diabetes and CKD?
  • Google Scholar

Similar Articles

Related Articles

  • Community-Based CKD Screening in Black Americans
  • PubMed
  • Google Scholar

Keywords

  • chronic kidney disease
  • clinical nephrology
  • ethnicity
  • adult
  • United States
  • Female
  • prevalence
  • Incidence
  • focus groups
  • Motivation
  • Research Personnel
  • Tennessee
  • African Americans
  • kidney diseases
  • Kidney Failure, Chronic
  • kidney
  • fear
  • emotions

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire